Myocardial Fibrosis: Symptoms, Causes, and Diagnosis - Healthline
May 17, 2023 · In this article, we take a deeper look at myocardial fibrosis, including the types, causes, and treatment options.
Cardiac fibrosis - PubMed
May 25, 2021 · This review article discusses the molecular mechanisms involved in the pathogenesis of cardiac fibrosis in various myocardial diseases, including myocardial infarction, heart failure with …
Cardiac fibrosis - Wikipedia
Cardiac fibrosis commonly refers to the excess deposition of extracellular matrix in the cardiac muscle, but the term may also refer to an abnormal thickening of the heart valves due to inappropriate …
What Is Cardiac Fibrosis and How Does It Affect the Heart?
Aug 4, 2025 · Cardiac fibrosis involves the excessive buildup of extracellular matrix (ECM) proteins, primarily collagen, within the heart tissue. This process is a response to various forms of cardiac …
Cardiac fibrosis – A short review of causes and therapeutic strategies
Jun 1, 2019 · In this review, we present an overview of what is known about cardiac fibrosis including the role of cardiac cells and extracellular matrix in this disease. We will further summarize current …
Cardiac Fibrosis | Circulation Research - AHA/ASA Journals
Mar 18, 2016 · This review summarizes current knowledge regarding the origins and roles of fibroblasts, mediators and signaling pathways known to influence fibroblast function after myocardial injury, as …
Myocardial Fibrosis: Symptoms, Diagnosis, and Treatment
Feb 16, 2024 · Myocardial fibrosis is a condition that involves the buildup of scar tissue in the myocardium, which is the heart muscle. Anything that causes damage to the heart can lead to scar …
Cardiac fibrosis: from mechanisms and models to medicines
Aug 27, 2025 · This review synthesizes emerging molecular mechanisms, experimental models, and preclinical and clinical investigations of antifibrotic agents. Distinct from previous reviews, we …
Cardiac fibrosis | Cardiovascular Research | Oxford Academic
Nov 2, 2020 · This review article discusses the molecular mechanisms involved in the pathogenesis of cardiac fibrosis in various myocardial diseases, including myocardial infarction, heart failure with …
Although clinical trials for this therapy in cardiac fibrosis have not yet commenced, promising preclinical results and ongoing refinements suggest that engineered immune cell therapy could ofer a …